Meeting
2018 ASCO Annual Meeting
Predicting neo-adjuvant chemotherapy response from pre-treatment breast MRI using machine learning and HER2 status.
Authors
Nathaniel Braman
Case Western Reserve University, Cleveland, OH
Nathaniel Braman , Kavya Ravichandran , Andrew Janowczyk , Jame Abraham , Anant Madabhushi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Neoadjuvant Therapy
Citation
J Clin Oncol 36, 2018 (suppl; abstr 582)
DOI
10.1200/JCO.2018.36.15_suppl.582
Abstract #
582
Poster Bd #
74
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial).
First Author: Ji-Jung Jung
Poster
2022 ASCO Annual Meeting
Deep learning algorithm to predict pathologic complete response to neoadjuvant chemotherapy for breast cancer prior to treatment.
First Author: Rachel Choi
Poster
2019 ASCO Annual Meeting
Development and external validation of a deep learning model for predicting response to HER2-targeted neoadjuvant therapy from pretreatment breast MRI.
First Author: Manasa Vulchi
Poster
2017 ASCO Annual Meeting
ACRIN 6698 trial: Quantitative diffusion-weighted MRI to predict pathologic response in neoadjuvant chemotherapy treatment of breast cancer.
First Author: Savannah C. Partridge